title: Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy.
authors.affiliation: First Department of Surgery, University School of Medicine, Vienna, Austria.
authors.forename: G
authors.initials: G
authors.lastname: Hamilton
authors.forename: F
authors.initials: F
authors.lastname: Mühlbacher
authors.forename: R
authors.initials: R
authors.lastname: Steininger
authors.forename: M
authors.initials: M
authors.lastname: Havel
authors.forename: S
authors.initials: S
authors.lastname: Kreuzer
authors.forename: F
authors.initials: F
authors.lastname: Laengle
authors.forename: F
authors.initials: F
authors.lastname: Piza
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000097:blood / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D006801:Humans; D016031:Liver Transplantation; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D012016:Reference Values
chemical_list: D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone